Nafazatrom
Product Specifications
Target
Lipoxygenase|||Others
Related Pathways
Others|||Metabolism
Bioactivity
Nafazatrom is a pyrazolinone derivative and lipoxygenase inhibitor that increases endogenous prostacyclin (PGI2) and has experimental anticancer activity. Nafazatrom is also an antithrombotic drug that increases prostacyclin levels and reduces the incidence of arrhythmias associated with cardiac injury.
Smiles
O(CCN1N=C(C)CC1=O)C2=CC3=C(C=C2)C=CC=C3
Molecular Formula
C16H16N2O2
Molecular Weight
268.31
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/DC055022-B7C7-4D0F-B4CA-9D00C05FD94E/T33579
CAS Number
59040-30-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items